LabChip GX Touch系列产品自动将样品与嵌入染料混合，使用电泳来分离和分析 DNA 样品，使用仪器光学检测激光诱导的荧光信号，并实现自动数据分析，使用Ladder和校准标准的Marker来确定片段大小和浓度。此外，数字数据结果还可以以虚拟凝胶、电泳图或表格摘要形式查看。

LabChip GX Touch系列产品不单可以完全取代传统的手工胶电泳，为各个分子生物学实验室提供更高重复性的、数字化的电泳数据，更由于其高灵敏度、适用样品范围广、通量灵活、快速等特点，而被广泛应用于高通量测序的样品及文库质控，各种分子标记检测，病原体、转基因与畜产品检测，种质资源管理与检定、合成生物学等多个领域。

一次可以运行1-96（96孔板）或1-384个（384孔板）样品。

DNA或RNA样品进行高通量电泳分离和定性、定量分析。

At Revvity, we regard "impossibility" as inspiration and "inability" as the driving force. Revvity offers health science solutions, cutting - edge technologies and professional services, with its business covering the entire end - to - end process of scientific research exploration, development, diagnosis, and treatment. Relying on years of in - depth cultivation in fields such as translational multi - omics technology, biomarker identification, imaging, disease prediction, screening, detection and diagnosis, and informatics, Revvity is using the power of technology to break through the boundaries of human potential.

In 2023, Revvity's turnover exceeded $2.7 billion. It has more than 11,000 employees worldwide and provides diverse services for customers such as pharmaceutical and biotechnology enterprises, diagnostic laboratories, scientific research institutions and government agencies. The company is a member of the S&P 500 Index, and its customers are spread across more than 190 countries and regions around the world.